Testosterone Science

Diabetes, Metabolic Health and Body Composition

Testosterone Levels Increase After Treatment With GLP-1 Receptor Agonists

Specific Claim Evaluated

In a retrospective analysis of 1,629 obese men treated with semaglutide or tirzepatide, median total testosterone rose from 320 to 419 ng/dL; causality cannot be established.

Primary Research Supporting or Contradicting the Claim

A meta-analysis found that GLP-1 receptor agonists increased total testosterone in overweight and obese men, with the change correlated with weight loss, and could not demonstrate a direct testicular action (Salvio et al., 2025).

Corrected Evidence-Based Interpretation

The report is correct.

Rationale for Grade

The article reports the retrospective design, nonstandardized timing of testosterone measurement and possible residual confounding, and presents GLP-1 receptor agonists as an adjunct rather than a replacement for standard treatment.

References

  1. Salvio G, Ciarloni A, Ambo N, Bordoni M, Perrone M, Rossi S, Balercia G. Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: a systematic review and meta-analysis. Andrology. 2025;13(8):2022-2034. PMID
    Supporting excerpt: "The limitations of the current literature do not allow to demonstrate a direct action"

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.